SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sept. 6, 2006--Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD, President & Chief Executive Officer, will present a company update at the Bear Stearns 19th Annual Healthcare Conference on Tuesday, September 12th at 4:30pm EDT in Ballroom D at The Grand Hyatt at Grand Central Station, New York, NY.
